Capital International Investors Sarepta Therapeutics, Inc. Transaction History
Capital International Investors
- $511 Billion
- Q4 2024
A detailed history of Capital International Investors transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Capital International Investors holds 8,697,137 shares of SRPT stock, worth $924 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
8,697,137
Previous 6,259,282
38.95%
Holding current value
$924 Million
Previous $782 Million
35.27%
% of portfolio
0.21%
Previous 0.16%
Shares
10 transactions
Others Institutions Holding SRPT
# of Institutions
536Shares Held
87.4MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$1.1 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$966 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$460 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$433 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.87MShares$305 Million1.85% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $9.31B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...